Search results for query: *

http://www.bionure.com/news/bionure-initiates-a-phase-1-clinical-trial-of-its-lead-compound-bn201-in-the-united-kingdom About BN201 and BN119 Bionure’s compounds BN201 and BN119 are two SGK agonists with remyelinating and neuroprotective activity. Bionure has developed BN201 for the treatment...

http://investors.otonomy.com/phoenix.zhtml?c=234082&p=irol-newsArticle_Print&ID=2325672 Developing OTO-313, an improved formulation of gacyclidine for the treatment of tinnitus. Gacyclidine is a potent and selective N-Methyl-D-Aspartate (NMDA) receptor antagonist, a molecular class with...

http://investors.otonomy.com/phoenix.zhtml?c=234082&p=irol-newsArticle_Print&ID=2325672 OTO-413 is a sustained exposure formulation of BDNF that has been advanced into IND-enabling activities for the treatment of hidden hearing loss. OTO-413 is a proprietary formulation of brain-derived...

https://autifony.com/ Boehringer Ingelheim and Autifony Therapeutics Limited (“Autifony”) today announced that they have signed an agreement about certain aspects of Autifony’s voltage gated potassium channel modulator platform. Boehringer Ingelheim now has an exclusive option to purchase...

Spiral Therapeutics Receives Positive IND Submission Guidance from FDA LPT99 is currently being tested for the treatment of other hearing loss indications, including noise-induced hearing loss and age-related hearing loss. Clinical trials for LPT99 will begin in early 2018...

http://www.isiet2017.org/ This could be interesting :)

Could it be that this new drug could also help on T. ? http://www.cnbc.com/2017/02/24/new-drugs-may-stop-migraines-before-they-start.html

Hi, Is there anyone who has tried this here? http://www.tinnitus.cc/en/our-offer/index.php